Using a blood test to find prostate cancer early
Part of Cancer, Kidney & urinary clinical trials.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male aged 18 or older.
- You must have a PSA level above 4.0 ng/mL, confirmed by two tests at least 4 weeks apart (unless you have very high or rising PSA).
- You may also qualify if you have abnormal prostate exam (DRE), suspicious MRI (PI-RADS 3 or higher), or a first-degree relative with prostate cancer.
- You must not have had certain recent procedures like a prostate biopsy within 6 weeks, or a urinary catheter within 4 weeks.
- You must not have another active cancer (except non-melanoma skin cancer) or serious kidney/liver problems.
- You must not be taking blood thinners that you can't stop for at least 5 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new artificial intelligence test to look for tiny amounts of cancer DNA in your blood. It aims to help catch prostate cancer earlier, when it may be easier to treat.
This trial tests if using MRI and a blood test called PHI can help decide who needs a prostate biopsy. It aims to avoid unnecessary biopsies while still catching cancer early.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
This study explores using repeated MRI scans to catch prostate cancer early in men who have never had a biopsy. If you have a suspicious spot on an MRI, you might be able to get careful monitoring without immediate biopsy, which could help avoid unnecessary procedures.
This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.